Fireside Chat: Investing with Intention – How Early Vision and Partnership Shaped Opus Genetics

Session details:

When venture firms take a hands-on approach to company creation, the results can redefine how science gets translated. In this fireside chat, Christy Shaffer, General Partner at Hatteras Venture Partners, sits down with Ben Yerxa, CEO of Opus Genetics, to unpack how they partnered from day one to build a company focused on treating rare inherited retinal diseases. From initial investment to scientific direction and team formation, hear how a strong investor-founder partnership shaped Opus’s path.

• Gain insight into how early investor involvement can catalyze R&D focus and execution
• Understand the dynamics that create productive, founder-investor collaboration
• Learn how Opus is navigating the rare disease space with strategic discipline